20 May 2021

The Association of European Cancer Leagues (ECL), the European Fair Pricing Network (EFPN), the European Public Health Alliance (EPHA) and the European Society for Paediatric Oncology (SIOP Europe) recently co-hosted a timely and interactive policy dialogue focused on strengthening EU Regulations for medicines targeting children and rare diseases.

During the discussion, participants explored concrete recommendations to accelerate access to high-quality, safe and affordable treatments, highlighting the urgent actions Europe should prioritise to ensure all patients benefit from timely and equitable care.